Organization
University of L’Aquila, Department of Biotechnological and Applied Clinical Sciences, L’Aquila, Italy
4 abstracts
Abstract
ADULT-ONSET STILL’S DISEASE WITH ELDERLY ONSET, RESULTS FROM A MULTICENTRE STUDY AND ASSESSMENT OF AGE INFLUENCE ON CLINICAL FEATURES AND DISEASE OUTCOMES.Org: University of L’Aquila, Department of Biotechnological and Applied Clinical Sciences, L’Aquila, Italy, University of Campania “Luigi Vanvitelli”, Department of Precision Medicine, Naples, Italy, Fondazione IRCCS Policlinico San Matteo, Rheumatology Department, Pavia, Italy, University of Siena, Department of Medical Sciences, Surgery and Neurosciences, Siena, Italy, University of Naples Federico II, Department of Clinical Medicine and Surgery, Naples, Italy,
Abstract
A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS)Org: UCB Pharma, Newcastle University, Strasbourg University Hospital, University of Palermo, Université Paris-Sud,
Abstract
A DIMINISHED EXPRESSION OF THE UBIQUITIN-PROTEASOME SYSTEM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND DIABETES IS LINKED TO IL-1 PATHWAY HYPER-ACTIVITYOrg: University of L’Aquila, Department of Biotechnological and Applied Clinical Sciences, L’Aquila, Italy, University of Rome “Campus Biomedico”, Unit of Rheumatology and Clinical Immunology, Rome, Italy, Queen Mary University of London, Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom,
Abstract
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONSOrg: University of L’Aquila, Department of Biotechnological and Applied Clinical Sciences, L’Aquila, Italy,